The first active distribution was launched in September 2020 and piloted in 11 health districts. After three rounds of active distributions, CAMEBU scaled-up the strategy to all the 48 health districts of the country.
With the assistance of USAID through GHSC-PSM, quarterly quality monitoring, re-evaluation and improvement of the active distribution strategy were organized so that any bottlenecks that arise can be resolved quickly, without disrupting the system.
CAMEBU, in collaboration with national programs and GHSC-PSM, organized a workshop in December 2021 to assess the active distribution strategy, evaluate the findings, discuss the flaws and make changes to improve the system.
To date, with the 5th round of active distribution, GHSC-PSM has assisted CAMEBU in distributing 107,325 Artemether/Lumefantrine 120/20 mg treatments and 83,686 TLD90 to manage HIV and malaria case rates while reducing mortality for children and adults, with more than 80% of these patients receiving ARV multi-month provisions.
The overall goal of GHSC-PSM in Burundi is to strengthen key government institutions and create long-term systems to ensure the availability and security of vital health commodities for the people of Burundi.
